{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:40:57Z","timestamp":1760834457109,"version":"build-2065373602"},"reference-count":23,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2013,11,28]]},"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Pertrochanteric hip fractures occur in an elderly population and cause considerable morbidity and loss of functional ability as the fracture heals. Recently, parathyroid hormone (PTH), which is licensed for the treatment of osteoporosis, has been shown to potentially accelerate bone healing in animal and human studies. If its administration could allow a faster functional recovery after pertrochanteric hip fracture, then a patient's hospital stay may be reduced and rehabilitation could be potentially accelerated. PTH can currently only be administered by subcutaneous injection. The acceptability of this intervention is unknown in this elderly population. The aim of this pilot study is to inform the design of a future powered study comparing the functional recovery after pertrochanteric hip fracture in patients undergoing standard care versus those who undergo administration of subcutaneous injection of PTH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>The study is an open label, prospective, randomised, comparative pilot study with blinded outcomes assessment to establish feasibility of the trial design. Patients will be randomised to receive a 6-week course of PTH or usual treatment. Functional outcomes will be assessed at 6\u2005weeks and 12\u2005weeks. Blinded assessment will be used to minimise the effect of bias of an open label study design. A nested qualitative study will investigate the patient experience of, and expectations following, hip fracture and the patient important aspects of recovery compared with the outcome measures proposed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Results will be analysed to establish the potential recruitment, compliance and retention rates using 95% CIs, and trial outcomes quoted with SDs and 95% CIs for the effect size.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study has been approved by the South West 2 Research Ethics committee (reference 10\/H0206\/34). The findings of this study will be disseminated to the medical community via presentations to orthopaedic, orthogeriatric and osteoporosis societies, and their relevant specialist journals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial Registration<\/jats:title>\n                  <jats:p>ISRCTN Register reference number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"03362357\">ISRCTN03362357<\/jats:ext-link>.<\/jats:p>\n                  <jats:p>Eudract Number: 2010-020081-22<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2013-004389","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T21:38:24Z","timestamp":1391031504000},"page":"e004389","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The administration of intermittent parathyroid hormone affects functional recovery from pertrochanteric fractured neck of femur: a protocol for a prospective mixed method pilot study with randomisation of treatment allocation and blinded assessment (FRACTT)"],"prefix":"10.1136","volume":"4","clinical-trial-number":[{"clinical-trial-number":"isrctn03362357","registry":"10.18810\/isrctn"}],"author":[{"given":"Tim","family":"Chesser","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Frenchay Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Frenchay Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Frenchay Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Greenwood","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol NHS Foundation Trust, Level 3 Education Centre, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassim","family":"Javaid","sequence":"additional","affiliation":[{"name":"NIHR Botnar Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedic Surgery, Nuffield Orthopaedic Centre, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Barnfield","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Frenchay Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Halliday","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Frenchay Hospital, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Willett","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kadoorie Critical Care Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie","family":"Lamb","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kadoorie Critical Care Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"2025101814531052000_4.1.e004389.1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.6.1139"},{"key":"2025101814531052000_4.1.e004389.2","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-200110000-00006"},{"key":"2025101814531052000_4.1.e004389.3","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg081"},{"key":"2025101814531052000_4.1.e004389.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9360-5"},{"key":"2025101814531052000_4.1.e004389.5","first-page":"1","article-title":"Systemic administration of PTH 1\u201384 for fracture repair: an exciting prospect","volume":"93","author":"Einhorn","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"2025101814531052000_4.1.e004389.6","doi-asserted-by":"publisher","DOI":"10.1385\/BMM:4:4:269"},{"key":"2025101814531052000_4.1.e004389.7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2106\/JBJS.G.01443","article-title":"Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment","volume":"90A","author":"Barnes","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"2025101814531052000_4.1.e004389.8","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.4.441"},{"key":"2025101814531052000_4.1.e004389.9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3928\/0147-7447-20001001-22","article-title":"Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectamized rats","volume":"23","author":"Jahng","year":"2000","journal-title":"Orthopedics"},{"key":"2025101814531052000_4.1.e004389.10","doi-asserted-by":"publisher","DOI":"10.1080\/00016470152846673"},{"key":"2025101814531052000_4.1.e004389.11","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199909000-00033"},{"key":"2025101814531052000_4.1.e004389.12","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.83B3.10256"},{"key":"2025101814531052000_4.1.e004389.13","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.D.02115"},{"key":"2025101814531052000_4.1.e004389.14","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2.6.993"},{"key":"2025101814531052000_4.1.e004389.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0358"},{"key":"2025101814531052000_4.1.e004389.16","unstructured":"Charmaz K . Constructing grounded theory: a practical guide through qualitative analysis. London: Sage, 2006."},{"key":"2025101814531052000_4.1.e004389.17","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.01379"},{"key":"2025101814531052000_4.1.e004389.18","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090731"},{"key":"2025101814531052000_4.1.e004389.19","unstructured":"National Institute for Health and Clinical Evidence. Venous thromboembolism; reducing the risk: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. 2010. http:\/\/www.nice.org.uk\/nicemedia\/live\/12695\/47195\/47195.pdf (accessed Mar 2010)."},{"key":"2025101814531052000_4.1.e004389.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0239"},{"key":"2025101814531052000_4.1.e004389.21","unstructured":"National Institute for Clinical Excellence (NICE). Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended). 2010. http:\/\/www.nice.org.uk\/nicemedia\/live\/11748\/47177\/47177.pdf (accessed Mar 2010)."},{"key":"2025101814531052000_4.1.e004389.22","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.2.M85"},{"key":"2025101814531052000_4.1.e004389.23","unstructured":"Grbich C . Qualitative research in health; an introduction. London: Sage, 1999."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-004389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:53:21Z","timestamp":1760824401000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-004389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,29]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1136\/bmjopen-2013-004389"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-004389","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}